Intent to Sole Source - Olink Reagents

Closed Special Notice Posted

Solicitation number
NOI-CC-OLAO-26-006363
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Bethesda, Maryland 20892, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institutes of Health, Clinical Center issued a Notice of Intent on June 11, 2026 to sole-source Olink reagents to Olink Proteomics Inc., with a capability statement deadline of June 21, 2026 at 12:00 PM Eastern time. This is not a request for proposal. The sole-source justification rests on FAR 6.302-1 (only one responsible source): Olink Proteomics manufactures the Q100 Instrument and is the sole supplier of reagents compatible with it, as the instrument accepts only validated Olink reagents and no other vendor supplies compatible alternatives. Any responsible source that could fulfill the requirement may submit a capability statement by email to valerie.gregorio@nih.gov with subject line NOI-OLAO-CC-26-006363. All statements received by the closing date will be reviewed, though the Government retains sole discretion to award on a sole-source basis or compete the requirement based on responses received.

Notice text

This is a Notice of Intent, not a request for proposal.  The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Olink Proteomics Inc.

Acquistion Description:

Olink Proteomics Inc. is the manufacturer of Q100 Instrument and the only company that sell reagents compatible with the Q100 Instrument. The Olink Q100 Instrument will only validated Olink reagents. No other vendor supplies reagents compatible with the Olink® Q100 Instrument.

The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.  All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-26-006363) by 12:00 PM eastern standard time on 06/21/2026 to: valerie.gregorio@nih.gov.

All responses received by the closing date of this synopsis will be considered by the Government.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

Similar open opportunities

Opportunity Agency Set-aside Responses due
Notice of Intent - Illumina MiSeq i100 series instruments Bethesda, Maryland 20892, United States · NAICS 334516 NIH Clinical Center No set-aside
Intent to Sole Source - Extended Support Renewal for Dell Unity 400 Bethesda, Maryland 20892, United States · NAICS 33411 NIH Clinical Center No set-aside
J065--Notice of Intenet to Sole Source- Life Technologies Corporation Maintenance and Service for QuantStudio 12K Flex Real-Time Quantitation System NAICS 811210 Veterans Integrated Service Network 16 No set-aside
Notice of Intent to Sole Source – Philips North America Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside
Equipment: Lonza 4D-Nucleofector® System Bethesda, Maryland 20892, United States · NAICS 334516 National Institute of Child Health and Human Development No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors